Pharmaceutical scientists have discovered an innovative way of bringing drugs by way of thin films that are either absorbed or dissolved in the mouth. It is owing to the rapid dissolution of OTF drugs that they have increased in popularity. The rising geriatric population has led to a greater demand for advanced methods of drug delivery to prevent chronic diseases such as diabetes. Oral thin film drug market growth is anticipated to be boosted by increasing investment in research and development (R&D) by companies to create dissolvable solutions for other diseases. OTF drugs can be a good revenue source for the market if they are presented in developing countries. The eruption of COVID-19 impacted the market. People sorrow from schizophrenia and migraine had a higher risk of mortality from COVID-19. For instance, as per the JAMA Psychiatry journal published in January 2021, grownups with a schizophrenia spectrum disorder diagnosis were related to an augmented risk for mortality with COVID-19.

Oral Thin Film Drugs Market trends was valued at USD 3.4 billion in 2022 and is projected to grow from USD 3.7 Billion in 2023 to USD 6.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.01% during the forecast period (2023 - 2030). 

Regional Analysis

In the North American area, the United States signified the biggest piece of the pie, as a significant part of the populace is moving toward schizophrenia drug treatments, basically because of rushed ways of life. Moreover, the nation offers profoundly progressed clinical consideration, for early treatment abilities, together with the association of the public authority in increasing medical services consumption. This is pouring the development of the oral thin film drugs market.

Market Segmentation

The global Oral Thin Film Drugs Market Research report has been segmented into product type, application, and end user.

Based on type, The global Oral Thin Film Drugs Market has been segmented into Sublingual Film, and Fast Dissolving Dental/Buccal Film. The sublingual film refers to oral thin films that speedily dissolve under the tongue and are quickly absorbed by blood with the help of tissue. It is cast-off to treat patients who are recovering from opioid misuse disorder. These oral thin films are cast off in the treatment of schizophrenia, migraine, opioid dependence, nausea, and vomiting. They are sold through hospice pharmacies, retail pharmacies, and other distribution networks.

Key Players

Some of the key market players are Johnson and Johnson Services, LTS Lohmann Therapie-Systeme AG (Germany), GlaxoSmithKline Plc (U.K.), Indivior Plc (U.S.), Pfizer Inc. (U.S.), CURE Pharmaceutical (U.S.), and Novartis AG (Switzerland)

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America